Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in the first-line treatment of patients with recurrent and/or metastatic squamous cell …

JB Vermorken, R Mesia, ME Vega-Villegas… - Journal of Clinical …, 2006 - ascopubs.org
5537 Background: The epidermal growth factor receptor (EGFR) is expressed in nearly all
SCCHN and carries a strong prognostic significance, providing the rationale for using EGFR …
被引用次数：30 相关文章

[引用][C] Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in the first-line treatment of patients with recurrent and/or metastatic squamous …

V JB - Proc Am Soc Clin Oncol, 2006 - cir.nii.ac.jp
Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in the first-line
treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and …